462 related articles for article (PubMed ID: 22587612)
1. Xanthine oxidase inhibition prevents atrial fibrillation in a canine model of atrial pacing-induced left ventricular dysfunction.
Sakabe M; Fujiki A; Sakamoto T; Nakatani Y; Mizumaki K; Inoue H
J Cardiovasc Electrophysiol; 2012 Oct; 23(10):1130-5. PubMed ID: 22587612
[TBL] [Abstract][Full Text] [Related]
2. Tranilast prevents atrial remodeling and development of atrial fibrillation in a canine model of atrial tachycardia and left ventricular dysfunction.
Nakatani Y; Nishida K; Sakabe M; Kataoka N; Sakamoto T; Yamaguchi Y; Iwamoto J; Mizumaki K; Fujiki A; Inoue H
J Am Coll Cardiol; 2013 Feb; 61(5):582-8. PubMed ID: 23273396
[TBL] [Abstract][Full Text] [Related]
3. Effects of simvastatin on the development of the atrial fibrillation substrate in dogs with congestive heart failure.
Shiroshita-Takeshita A; Brundel BJ; Burstein B; Leung TK; Mitamura H; Ogawa S; Nattel S
Cardiovasc Res; 2007 Apr; 74(1):75-84. PubMed ID: 17270161
[TBL] [Abstract][Full Text] [Related]
4. Effects of amiodarone on electrical and structural remodeling induced in a canine rapid pacing-induced persistent atrial fibrillation model.
Ashikaga K; Kobayashi T; Kimura M; Owada S; Sasaki S; Iwasa A; Furukawa K; Motomura S; Okumura K
Eur J Pharmacol; 2006 Apr; 536(1-2):148-53. PubMed ID: 16556442
[TBL] [Abstract][Full Text] [Related]
5. Effect of simvastatin and antioxidant vitamins on atrial fibrillation promotion by atrial-tachycardia remodeling in dogs.
Shiroshita-Takeshita A; Schram G; Lavoie J; Nattel S
Circulation; 2004 Oct; 110(16):2313-9. PubMed ID: 15477401
[TBL] [Abstract][Full Text] [Related]
6. Omega-3 polyunsaturated fatty acids prevent atrial fibrillation associated with heart failure but not atrial tachycardia remodeling.
Sakabe M; Shiroshita-Takeshita A; Maguy A; Dumesnil C; Nigam A; Leung TK; Nattel S
Circulation; 2007 Nov; 116(19):2101-9. PubMed ID: 17967774
[TBL] [Abstract][Full Text] [Related]
7. Atrial fibrillation-associated remodeling does not promote atrial thrombus formation in canine models.
Nishida K; Chiba K; Iwasaki YK; Katsouras G; Shi YF; Blostein MD; Khairy P; Guerra PG; Dubuc M; Tardif JC; Tanguay JF; Nattel S
Circ Arrhythm Electrophysiol; 2012 Dec; 5(6):1168-75. PubMed ID: 23095228
[TBL] [Abstract][Full Text] [Related]
8. Xanthine oxidase inhibition ameliorates cardiovascular dysfunction in dogs with pacing-induced heart failure.
Amado LC; Saliaris AP; Raju SV; Lehrke S; St John M; Xie J; Stewart G; Fitton T; Minhas KM; Brawn J; Hare JM
J Mol Cell Cardiol; 2005 Sep; 39(3):531-6. PubMed ID: 15963530
[TBL] [Abstract][Full Text] [Related]
9. Rate-dependence of atrial tachycardia effects on atrial refractoriness and atrial fibrillation maintenance.
Shiroshita-Takeshita A; Mitamura H; Ogawa S; Nattel S
Cardiovasc Res; 2009 Jan; 81(1):90-7. PubMed ID: 18801748
[TBL] [Abstract][Full Text] [Related]
10. Effect of irbesartan on development of atrial fibrosis and atrial fibrillation in a canine atrial tachycardia model with left ventricular dysfunction, association with p53.
Kataoka N; Nishida K; Kinoshita K; Sakamoto T; Nakatani Y; Tsujino Y; Mizumaki K; Inoue H; Kinugawa K
Heart Vessels; 2016 Dec; 31(12):2053-2060. PubMed ID: 27236656
[TBL] [Abstract][Full Text] [Related]
11. Changes in connexin expression and the atrial fibrillation substrate in congestive heart failure.
Burstein B; Comtois P; Michael G; Nishida K; Villeneuve L; Yeh YH; Nattel S
Circ Res; 2009 Dec; 105(12):1213-22. PubMed ID: 19875729
[TBL] [Abstract][Full Text] [Related]
12. d,l-Sotalol reverses abbreviated atrial refractoriness and prevents promotion of atrial fibrillation in a canine model with left ventricular dysfunction induced by atrial tachypacing.
Sakamoto T; Fujiki A; Nakatani Y; Sakabe M; Mizumaki K; Hashimoto N; Inoue H
Circ J; 2009 Oct; 73(10):1820-8. PubMed ID: 19713653
[TBL] [Abstract][Full Text] [Related]
13. Antiremodeling Effect of Xanthine Oxidase Inhibition in a Canine Model of Atrial Fibrillation.
Yoshizawa T; Niwano S; Niwano H; Tamaki H; Nakamura H; Igarashi T; Oikawa J; Satoh A; Kishihara J; Murakami M; Fukaya H; Ako J
Int Heart J; 2018 Sep; 59(5):1077-1085. PubMed ID: 30158379
[TBL] [Abstract][Full Text] [Related]
14. Myocardial infarction and atrial fibrillation: importance of atrial ischemia.
Alasady M; Shipp NJ; Brooks AG; Lim HS; Lau DH; Barlow D; Kuklik P; Worthley MI; Roberts-Thomson KC; Saint DA; Abhayaratna W; Sanders P
Circ Arrhythm Electrophysiol; 2013 Aug; 6(4):738-45. PubMed ID: 23873140
[TBL] [Abstract][Full Text] [Related]
15. Prednisone prevents atrial fibrillation promotion by atrial tachycardia remodeling in dogs.
Shiroshita-Takeshita A; Brundel BJ; Lavoie J; Nattel S
Cardiovasc Res; 2006 Mar; 69(4):865-75. PubMed ID: 16405878
[TBL] [Abstract][Full Text] [Related]
16. Altered atrial electrical restitution and heterogeneous sympathetic hyperinnervation in hearts with chronic left ventricular myocardial infarction: implications for atrial fibrillation.
Miyauchi Y; Zhou S; Okuyama Y; Miyauchi M; Hayashi H; Hamabe A; Fishbein MC; Mandel WJ; Chen LS; Chen PS; Karagueuzian HS
Circulation; 2003 Jul; 108(3):360-6. PubMed ID: 12835207
[TBL] [Abstract][Full Text] [Related]
17. Effects of spironolactone on electrical and structural remodeling of atrium in congestive heart failure dogs.
Yang SS; Han W; Zhou HY; Dong G; Wang BC; Huo H; Wei N; Cao Y; Zhou G; Xiu CH; Li WM
Chin Med J (Engl); 2008 Jan; 121(1):38-42. PubMed ID: 18208664
[TBL] [Abstract][Full Text] [Related]
18. Rosiglitazone attenuates atrial structural remodeling and atrial fibrillation promotion in alloxan-induced diabetic rabbits.
Liu T; Zhao H; Li J; Korantzopoulos P; Li G
Cardiovasc Ther; 2014 Aug; 32(4):178-83. PubMed ID: 24814361
[TBL] [Abstract][Full Text] [Related]
19. Enalapril prevents perpetuation of atrial fibrillation by suppressing atrial fibrosis and over-expression of connexin43 in a canine model of atrial pacing-induced left ventricular dysfunction.
Sakabe M; Fujiki A; Nishida K; Sugao M; Nagasawa H; Tsuneda T; Mizumaki K; Inoue H
J Cardiovasc Pharmacol; 2004 Jun; 43(6):851-9. PubMed ID: 15167279
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinase inhibition attenuates atrial remodeling and vulnerability to atrial fibrillation in a canine model of heart failure.
Moe GW; Laurent G; Doumanovskaia L; Konig A; Hu X; Dorian P
J Card Fail; 2008 Nov; 14(9):768-76. PubMed ID: 18995182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
